These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 27634909
1. Biomarkers to detect membranous nephropathy in Chinese patients. Lin L, Wang WM, Pan XX, Xu J, Gao CN, Zhang W, Ren H, Xie JY, Shen PY, Xu YW, Ni LY, Chen N. Oncotarget; 2016 Oct 18; 7(42):67868-67879. PubMed ID: 27634909 [Abstract] [Full Text] [Related]
2. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy. Wang J, Cui Z, Lu J, Probst C, Zhang YM, Wang X, Qu Z, Wang F, Meng LQ, Cheng XY, Liu G, Debiec H, Ronco P, Zhao MH. Clin J Am Soc Nephrol; 2017 Oct 06; 12(10):1642-1651. PubMed ID: 28801527 [Abstract] [Full Text] [Related]
4. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China. Zhang D, Zou J, Zhang C, Zhang W, Lin F, Jiang G. Med Sci Monit; 2018 Jul 22; 24():5076-5083. PubMed ID: 30032157 [Abstract] [Full Text] [Related]
5. Clinical significance of M-type phospholipase A2 receptor and thrombospondin Type 1 domain-containing 7A in primary membranous nephropathy. Gong Z, Yuan S, Zhu X, Wang Y, Yu F, Yang D, Xu X, Liu H, Li J, Sun L. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun 28; 45(6):693-700. PubMed ID: 32879127 [Abstract] [Full Text] [Related]
8. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy. Hoxha E, Harendza S, Pinnschmidt HO, Tomas NM, Helmchen U, Panzer U, Stahl RA. Nephrol Dial Transplant; 2015 Nov 07; 30(11):1862-9. PubMed ID: 26142398 [Abstract] [Full Text] [Related]
9. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity. Larsen CP, Cossey LN, Beck LH. Mod Pathol; 2016 Apr 07; 29(4):421-6. PubMed ID: 26847174 [Abstract] [Full Text] [Related]
10. A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy. Wanderley DC, Jones BD, Barbosa FAM, Araujo SA. J Bras Nefrol; 2019 Oct 28; 42(2):254-258. PubMed ID: 31663595 [Abstract] [Full Text] [Related]
11. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy. Zaghrini C, Seitz-Polski B, Justino J, Dolla G, Payré C, Jourde-Chiche N, Van de Logt AE, Booth C, Rigby E, Lonnbro-Widgren J, Nystrom J, Mariat C, Cui Z, Wetzels JFM, Ghiggeri G, Beck LH, Ronco P, Debiec H, Lambeau G. Kidney Int; 2019 Mar 28; 95(3):666-679. PubMed ID: 30784662 [Abstract] [Full Text] [Related]
12. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain. L'Imperio V, Pieruzzi F, Sinico RA, Nebuloni M, Granata A, Smith A, Radice A, Pagni F. J Nephrol; 2018 Aug 28; 31(4):543-550. PubMed ID: 29626294 [Abstract] [Full Text] [Related]
14. PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy. Ge YC, Jin B, Zeng CH, Zhang MC, Chen DC, Yin R, Le WB. BMC Nephrol; 2016 Nov 22; 17(1):185. PubMed ID: 27876003 [Abstract] [Full Text] [Related]
15. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN. Ren S, Wu C, Zhang Y, Wang AY, Li G, Wang L, Hong D. Ren Fail; 2018 Nov 22; 40(1):306-313. PubMed ID: 29623759 [Abstract] [Full Text] [Related]
16. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Radice A, Trezzi B, Maggiore U, Pregnolato F, Stellato T, Napodano P, Rolla D, Pesce G, D'Amico M, Santoro D, Londrino F, Ravera F, Ortisi G, Sinico RA. Autoimmun Rev; 2016 Feb 22; 15(2):146-54. PubMed ID: 26527329 [Abstract] [Full Text] [Related]
17. Effects of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy. Yeter HH, Isik Gonul I, Eraslan E, Karacalik C, Ogut B, Guz G. Clin Exp Nephrol; 2021 May 22; 25(5):488-500. PubMed ID: 33459908 [Abstract] [Full Text] [Related]
18. Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans. Lwezaula BF, Ameh OI, Ekrikpo UE, Botha FC, Okpechi-Samuel US, Wearne N, Ronco P, Bello AK, Okpechi IG. BMC Nephrol; 2021 Jan 07; 22(1):15. PubMed ID: 33413188 [Abstract] [Full Text] [Related]
19. Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain. Fresquet M, Rhoden SJ, Jowitt TA, McKenzie EA, Roberts I, Lennon R, Brenchley PE. J Autoimmun; 2020 Jan 07; 106():102308. PubMed ID: 31395435 [Abstract] [Full Text] [Related]
20. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy]. Tang XL, DU YY, Yu J, Ye T, Zhu H, Chen YF, Li XH. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr 07; 45(2):235-244. PubMed ID: 37157070 [Abstract] [Full Text] [Related] Page: [Next] [New Search]